Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  itraconazole
Find trials that include:  Any drugs shown
Results 1-7 of 7 for your search:
Start Over
Itraconazole and Pemetrexed Disodium in Treating Patients With Previously Treated Non-Small Cell Lung Cancer
Phase: Phase II
Type: Supportive care, Treatment
Age: Over 18
Trial IDs: J0881, NCI-2010-02070, NCT00769600
Biomarkers in Tissue Samples From Patients With Basal Cell Skin Cancer Treated With Itraconazole
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: SKIN0004, NCI-2011-00419, 17365, NCT01108094
Itraconazole in Treating Patients With Biochemically Relapsed Prostate Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 125513, NCI-2013-02375, CC#125513, NCT01787331
Effects of Fluconazole and Itraconazole CYP3A-Mediated Inhibition on the Pharmacokinetics, Safety, and Tolerability of MLN4924 in Patients With Advanced Solid Tumors
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: C15011, NCI-2014-01685, U1111-1155-6191, NCT02122770
A Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of Alisertib in Patients With Advanced Solid Tumors or Relapsed/Refractory Lymphoma
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: C14020, NCI-2014-02213, NCT02259010
Itraconazole in Treating Patients with Basal Cell Carcinoma
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: J1299, NCI-2014-01255, NA_00077461, NCT02120677
Itraconazole in Preventing Blood Vessel Growth in Patients with Non-small Cell Lung Cancer Undergoing Surgery
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: SCCC-01515, NCI-2015-00458, NCT02357836
Start Over